Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8303
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sritharan, H. P. | - |
dc.contributor.author | Bhatia, K. S. | - |
dc.contributor.author | van Gaal, W. | - |
dc.contributor.author | Kritharides, L. | - |
dc.contributor.author | Chow, Clara K. | - |
dc.contributor.author | Bhindi, R. | - |
dc.date.accessioned | 2023-12-14T04:56:29Z | - |
dc.date.available | 2023-12-14T04:56:29Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Frontiers in Cardiovascular Medicine 10:1224886, 2023 | - |
dc.identifier.uri | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8303 | - |
dc.description.abstract | BACKGROUND: Pre-existing cardiovascular disease and cardiovascular risk factors are common in patients with COVID-19 and there remain concerns for poorer in-hospital outcomes in this cohort. We aimed to analyse the relationship between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in patients hospitalised with COVID-19 in a prospective, multicentre observational study. METHODS: This prospective, multicentre observational study included consecutive patients of age >=18 in their index hospitalisation with laboratory-proven COVID-19 in Australia. Patients with suspected but not laboratory-proven COVID-19 and patients with no available past medical history were excluded. The primary exposure was pre-existing cardiovascular disease, defined as a composite of coronary artery disease, heart failure or cardiomyopathy, atrial fibrillation or flutter, severe valvular disease, peripheral arterial disease and stroke or transient ischaemic attack. The primary outcome was in-hospital mortality. Secondary outcomes were clinical cardiovascular complications (new onset atrial fibrillation or flutter, high-grade atrioventricular block, sustained ventricular tachycardia, new heart failure or cardiomyopathy, pericarditis, myocarditis or myopericarditis, pulmonary embolism and cardiac arrest) and myocardial injury. RESULTS: 1,567 patients (mean age 60.7 (+/-20.5) years and 837 (53.4%) male) were included. Overall, 398 (25.4%) patients had pre-existing cardiovascular disease, 176 patients (11.2%) died, 75 (5.7%) had clinical cardiovascular complications and 345 (37.8%) had myocardial injury. Patients with pre-existing cardiovascular disease had significantly increased in-hospital mortality (aOR: 1.76 95% CI: 1.21-2.55, p = 0.003) and myocardial injury (aOR: 3.27, 95% CI: 2.23-4.79, p < 0.001). There was no significant association between pre-existing cardiovascular disease and in-hospital clinical cardiovascular complications (aOR: 1.10, 95% CI: 0.58-2.09, p = 0.766). On mediation analysis, the indirect effect and Sobel test were significant (p < 0.001), indicating that the relationship between pre-existing cardiovascular disease and in-hospital mortality was partially mediated by myocardial injury. Apart from age, other cardiovascular risk factors such as diabetes, hypercholesterolemia and hypertension had no significant impact on mortality, clinical cardiovascular complications or myocardial injury. Conclusions: Pre-existing cardiovascular disease is associated with significantly higher mortality in patients hospitalised with COVID-19. This relationship may be partly explained by increased risk of myocardial injury among patients with pre-existing cardiovascular disease which in turn is a marker associated with higher mortality. | - |
dc.subject | Cardiology | - |
dc.subject | Infections | - |
dc.title | Association between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in hospitalised patients with COVID-19 | - |
dc.type | Journal Article | - |
dc.identifier.doi | https://dx.doi.org/10.3389/fcvm.2023.1224886 | - |
dc.subject.keywords | atrial fibrillation | - |
dc.subject.keywords | Covid 19 | - |
dc.subject.keywords | Cardiovascular Diseases | - |
dc.identifier.journaltitle | Frontiers in Cardiovascular Medicine | - |
dc.identifier.department | Cardiology | - |
dc.contributor.wslhd | Chow, Clara K. | - |
dc.type.studyortrial | Cohort Analysis | - |
dc.type.studyortrial | Meta Analysis | - |
dc.type.studyortrial | Major Clinical Study | - |
dc.type.studyortrial | Observational Study | - |
dc.identifier.pmid | 37476577 | - |
dc.identifier.affiliation | Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia | - |
dc.identifier.affiliation | Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia | - |
dc.identifier.affiliation | Department of Cardiology, Bankstown-Lidcombe Hospital, Sydney, NSW, Australia | - |
dc.identifier.affiliation | Department of Cardiology, Northern Hospital, Melbourne, VIC, Australia | - |
dc.identifier.affiliation | Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia | - |
dc.identifier.affiliation | Department of Cardiology, Concord Repatriation General Hospital, Sydney, NSW, Australia | - |
dc.identifier.affiliation | Westmead Applied Research Centre and Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia | - |
dc.identifier.facility | Blacktown | - |
dc.identifier.facility | Westmead | - |
Appears in Collections: | Blacktown Mount Druitt Hospital |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.